AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 53 filers reported holding AQUINOX PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $35,000 | -2.8% | 14,900 | -1.7% | 0.02% | -11.1% |
| Q4 2018 | $36,000 | -21.7% | 15,150 | -9.0% | 0.02% | -28.0% |
| Q3 2018 | $46,000 | -79.6% | 16,650 | +5.0% | 0.02% | -75.5% |
| Q2 2018 | $226,000 | -50.0% | 15,850 | -50.0% | 0.10% | -23.9% |
| Q1 2018 | $452,000 | +128.3% | 31,700 | +100.0% | 0.13% | +44.1% |
| Q4 2017 | $198,000 | – | 15,850 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 1,396,071 | $19,643,000 | 2.25% |
| Boxer Capital, LLC | 525,000 | $7,387,000 | 1.76% |
| Baker Brothers Advisors | 10,934,154 | $153,844,000 | 1.34% |
| EMORY UNIVERSITY | 105,815 | $1,489,000 | 1.32% |
| Ghost Tree Capital, LLC | 300,000 | $4,221,000 | 0.88% |
| UNIVERSITY OF NOTRE DAME DU LAC | 171,217 | $2,409,000 | 0.71% |
| NEXTHERA CAPITAL LP | 90,700 | $1,276,000 | 0.56% |
| Eventide Asset Management | 175,000 | $2,462,000 | 0.15% |
| SPHERA FUNDS MANAGEMENT LTD. | 62,085 | $874,000 | 0.15% |
| ASCEND CAPITAL, LLC | 214,328 | $3,017,000 | 0.14% |